Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in adults. According to the National Cancer Society an estimated 60,000 people are living throughout the United States with CLL.
An article published in The Lancet stated that the chemotherapy combination of Fludara plus Cytoxan improves progression free survival compared to therapy consisting of Fludara alone. The drugs used to treat CLL consist of Fludara, Cytoxan and chlorambucil. Recent studies have shown that Fludara in combination with Cytoxan to be the most effective treatment for CLL.
Researchers wanted to test to see if higher anticancer responses were seen with the combination of Fludara plus Cytoxan, treatment with Fludara alone or treatment with chlorambucil.
